A decision could arrive within weeks.
Protease inhibitors as a class of drugs are not new, Hsu said.
But they could be available soon.
Pierre Suu / Contributor / Getty Images
Why Did Pfizer Stop Clinical Trials Early?
Trials are designed with pre-specified interim analyses to determine efficacy and safety, Chupp said.
Experts say the FDA will likely come to a decision sooner than previously expected.
For the most recent updates on COVID-19, visit ourcoronavirus news page.
2021;35:205873842110026. doi.
